SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038436
Filing Date
2023-11-13
Accepted
2023-11-13 08:54:50
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q frtx-20230930.htm   iXBRL 10-Q 1020948
2 EX-3.1 a2023093010qex32.htm EX-3.1 106716
3 EX-10.5 a2023093010qex105.htm EX-10.5 111490
4 EX-10.6 a2023093010qex106.htm EX-10.6 85012
5 EX-10.7 a2023093010qex107.htm EX-10.7 128794
6 EX-31.1 a2023093010qex311.htm EX-31.1 10092
7 EX-32.1 a2023093010qex321.htm EX-32.1 8210
13 frtx-20230930_g1.jpg GRAPHIC 256028
  Complete submission text file 0001628280-23-038436.txt   5734591

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230930.xsd EX-101.SCH 35866
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frtx-20230930_cal.xml EX-101.CAL 32515
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frtx-20230930_def.xml EX-101.DEF 150704
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230930_lab.xml EX-101.LAB 479919
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230930_pre.xml EX-101.PRE 291802
50 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230930_htm.xml XML 472896
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 231395540
SIC: 2836 Biological Products, (No Diagnostic Substances)